Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-18-022178

EVP, Chief Financial Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bell Graeme · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-03-28 Exercise or conversion : show line 1 in the form +8,000 $13.48 $107,840 21,400 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-28 Exercise or conversion : show line 2 in the form Stock Option (Right to buy) −8,000 202,000 D
Loading xslF345X03/doc4.xml…